Wikipedia:Articles for deletion/Laborate Pharmaceuticals

The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.

The result was Delete--Anthony Bradbury^"talk" 10:36, 6 August 2016 (UTC)[reply]

Laborate Pharmaceuticals

(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

WP:NOTPROMO, fails WP:CORPDEPTH, sources fail WP:RS, and a likely undisclosed paid editor as well. Changed PROD to AfD to discourage any recreation that does not provide actual usable content. MSJapan (talk) 23:32, 30 July 2016 (UTC)[reply]

Note: This debate has been included in the list of Companies-related deletion discussions. North America¹⁰⁰⁰ 23:54, 30 July 2016 (UTC)[reply]

Note: This debate has been included in the list of Medicine-related deletion discussions. North America¹⁰⁰⁰ 23:54, 30 July 2016 (UTC)[reply]

Note: This debate has been included in the list of India-related deletion discussions. North America¹⁰⁰⁰ 23:54, 30 July 2016 (UTC)[reply]

Delete as original PRODding editor, where I wrote: Failed WP:CORP coverage-in-depth criterion. - Brianhe (talk) 05:17, 31 July 2016 (UTC)[reply]
Delete -- promo content on a non notable company. K.e.coffman (talk) 01:12, 1 August 2016 (UTC)[reply]
Delete and I frankly still consider this speedy delete material. SwisterTwister talk 02:33, 1 August 2016 (UTC)[reply]
Delete A lot of trivial mentions in news articles, some as part of a litigation, but not a single articles describes the company in detail. Accordingly, it fails WP:CORPDEPTH and should be deleted. --Lemongirl942 (talk) 14:31, 3 August 2016 (UTC)[reply]

The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.